Literature DB >> 28803449

Prospective comparison between magnetic resonance imaging and computed tomography in colorectal cancer staging.

Frederick H X Koh1, Ker-Kan Tan1,2, Lynette L S Teo3, Bertrand W L Ang3, Yee-Liang Thian3.   

Abstract

BACKGROUND: Diffusion-weighted (DW) imaging is a functional magnetic resonance imaging (MRI) technique that detects lesions with high cellularity, such as malignant tumours. This prospective study was performed to compare the accuracy of DW-MRI with multidetector computed tomography (MDCT) in staging of colorectal cancer.
METHODS: Thirty patients with histologically proven colorectal cancer were prospectively recruited. Each patient underwent both MDCT and DW-MRI of the abdomen-pelvis for primary staging. Images were evaluated for nodal and distant metastases. The reference standard was histopathological findings for nodal involvement and surveillance imaging for suspected hepatic metastases.
RESULTS: The primary cancers were located in the rectum (n = 16, 53.3%), sigmoid colon (n = 9, 30%) and right colon (n = 5, 16.6%). For nodal metastases, the sensitivity and specificity of DW-MRI were 84.6% (95% confidence interval (CI): 54.6-98.1%) and 20.0% (95% CI: 2.5-55.6%) compared with 84.6% (95% CI: 54.6-98.1%) and 40.0% (95% CI: 12.2-73.8%) for MDCT. For liver metastases, the sensitivity and specificity for DW-MRI were 100.0% (95% CI: 63.1-100.0%) and 100% (95% CI: 84.6-100%) compared with 87.5% (95% CI: 47.4-99.7%) and 95.5% (95% CI: 77.2-99.9%) for MDCT. DW imaging altered the clinical management in three (10.0%) patients by detecting missed hepatic metastases in two patients and accurately diagnosing another patient with a hepatic cyst, mistaken for metastasis on MDCT.
CONCLUSION: DW-MRI is more accurate for detecting hepatic metastases in colorectal cancer compared with MDCT.
© 2017 Royal Australasian College of Surgeons.

Entities:  

Keywords:  colorectal cancer; computed tomography; diffusion-weighted; magnetic resonance imaging; staging

Mesh:

Year:  2017        PMID: 28803449     DOI: 10.1111/ans.14138

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  3 in total

1.  Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases.

Authors:  B G Sibinga Mulder; K Visser; S Feshtali; A L Vahrmeijer; R J Swijnenburg; H H Hartgrink; R van den Boom; M C Burgmans; J S D Mieog
Journal:  BMC Med Imaging       Date:  2018-11-15       Impact factor: 1.930

2.  Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.

Authors:  M P Engbersen; C J V Rijsemus; J Nederend; A G J Aalbers; I H J T de Hingh; V Retel; D M J Lambregts; E J R J Van der Hoeven; D Boerma; M J Wiezer; M De Vries; E V E Madsen; A R M Brandt-Kerkhof; S Van Koeverden; P R De Reuver; R G H Beets-Tan; N F M Kok; M J Lahaye
Journal:  BMC Cancer       Date:  2021-04-26       Impact factor: 4.430

3.  CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study.

Authors:  Søren R Rafaelsen; Claus Dam; Chris Vagn-Hansen; Jakob Møller; Hans B Rahr; Mikkel Sjöström; Jan Lindebjerg; Torben Frøstrup Hansen; Malene Roland Vils Pedersen
Journal:  Curr Oncol       Date:  2022-02-13       Impact factor: 3.109

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.